✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Auro Laboratories Ltd.

AUROLAB

Market Cap
₹158 Cr.
P/E
85.69

Auro Laboratories Ltd.

  • Auro Laboratories
  • Astonea Labs
  • Sotac Pharmaceutical
FAQs on Auro Laboratories Ltd. Shareprice

Auro Laboratories has given better returns compared to its competitors.
Auro Laboratories has grown at ~77.69% over the last 2yrs while peers have grown at a median rate of 5.27%

Yes, Auro Laboratories is expensive.
Latest PE of Auro Laboratories is 86.08, while 3 year average PE is 21.88.
Also latest EV/EBITDA of Auro Laboratories is 61.27 while 3yr average is 14.86.

View FAQ's On Business
Growth Table
  • Auro Laboratories Ltd.
  • Astonea Labs
  • Sotac Pharmaceutical
Balance Sheet
  • Auro Laboratories Ltd.
  • Astonea Labs
  • Sotac Pharmaceutical
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Auro Laboratories Ltd.
  • Astonea Labs
  • Sotac Pharmaceutical
Cash Flow
  • Auro Laboratories Ltd.
  • Astonea Labs
  • Sotac Pharmaceutical
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Auro Laboratories Ltd.
  • Astonea Labs
  • Sotac Pharmaceutical
Quarterly Results
  • Auro Laboratories Ltd.
  • Astonea Labs
  • Sotac Pharmaceutical
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Auro Laboratories Ltd. Financials

Balance sheet of Auro Laboratories is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Auro Laboratories is increasing.
Latest net debt of Auro Laboratories is ₹44.38 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹22.95 Crs.

The profit is oscillating.
The profit of Auro Laboratories is ₹1.56 Crs for TTM, ₹7.79 Crs for Mar 2024 and ₹2.44 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Auro Laboratories latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Capital Work in Progress

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech